514 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Zydus Lifesciences recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The tablets contain N-Nitroso Desmethyl Chlorpromazine above safe intake levels. Consumers must stop using the product immediately and consult healthcare providers.
Philips Medical Systems Nederland B.V. recalled 46 imaging systems on September 3, 2025. Deterioration of internal components may lead to loss of motorized movements. Healthcare providers must stop using the systems immediately and follow recall instructions.
Philips Medical Systems Nederland B.V. recalled 174 OR tables on September 3, 2025. The recall affects models 722023, 722035, and 722015 due to potential failure of motorized movements. Users must stop using these devices immediately to prevent operational issues.
Philips Medical Systems Nederland B.V. recalled 115 Allura Xper FD20/20 medical imaging devices on September 3, 2025. The BIOS battery may deplete faster than expected, halting the system during startup. The recall affects 34 devices in the U.S. and 81 internationally.
Philips Medical Systems recalled 298 Allura Xper FD20 operating room tables on September 3, 2025, due to a faulty BIOS battery. The battery depletes faster than expected, halting system start-up without warning. This recall affects 72 units in the U.S. and 226 units distributed internationally.
Philips Medical Systems recalled 585 Allura Xper FD10/10 imaging systems on September 3, 2025. The BIOS battery may deplete faster than expected, halting system start-up. This affects models 722005, 722011, and 722027 distributed worldwide.
Philips Medical Systems Nederland B.V. recalled 87 Allura Xper FD20/10 medical imaging devices on September 3, 2025. The BIOS battery may deplete faster than expected, halting the system's start-up process without warning. Healthcare providers and patients should stop using these devices immediately.
Failed Impurities/Degradation Specifications
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD20 Biplane OR Table on September 3, 2025, due to a potential BIOS battery failure. The recall affects four units distributed globally, including two in the U.S. and two internationally.
Inpeco S.A. recalled eight units of its FlexLab (FLX) Potassium Test System on September 3, 2025. The system's Sample Integrity Module may produce erroneous results due to unverified functions. Healthcare providers must stop using the device immediately and follow the manufacturer's instructions.
Beckman Coulter recalled 2,146 units of SYNCHRON Systems Phosphorus reagents on September 3, 2025. The affected lots may fail calibration before expiration, delaying patient results. Healthcare providers must stop using the product immediately.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD10 Operating Room Table on September 3, 2025. The BIOS battery may deplete faster than expected, halting the system's start-up process. This recall affects two units distributed worldwide, including the U.S. and multiple countries.
Inpeco S.A. recalled one unit of the FlexLab X (FXX) System on September 3, 2025. The recall affects the Sample Integrity Module, which has not been FDA evaluated for safety. This may cause erroneous results or delays in patient testing.
Philips Medical Systems Nederland B.V. recalled 300 Allura Xper FD20/15 devices on September 3, 2025. The BIOS battery may deplete too quickly, halting system start-up. Users may not receive any warning before the battery fails.
Philips Medical Systems recalled 501 Allura Xper FD20 Biplane systems on September 3, 2025. The BIOS battery may deplete quickly, halting system startup without warning. The recall affects devices distributed worldwide, including the US and several countries in Europe and Asia.
Philips Medical Systems recalled 2,317 Allura Xper FD10 systems on September 3, 2025. The BIOS battery may deplete faster than expected, halting the system startup. Affected models include 722003, 722010, and 722026.
Philips Medical Systems Nederland B.V. recalled eight Allura Xper FD20/15 OR Tables on September 3, 2025. The BIOS battery may deplete unexpectedly, halting the system's start-up process. This recall affects two units in the U.S. and six units internationally.
Philips Medical Systems Nederland B.V. recalled 53 Allura Xper CV20 medical imaging systems on September 3, 2025. The BIOS battery may deplete faster than anticipated, halting the system's start-up process. Users will not receive warnings before the battery depletes.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD20/20 operating room table on September 3, 2025, due to a potential BIOS battery failure. The battery may deplete faster than expected, causing the system to halt without warning. This recall affects five units distributed worldwide.
Philips Medical Systems recalled 313 cardiac monitors on September 3, 2025, due to a BIOS battery issue. The battery may deplete unexpectedly, halting the device's start-up process without warning. Patients and healthcare providers must stop using the device immediately.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD10C model on September 3, 2025, due to a potential BIOS battery issue. The battery may deplete faster than expected, halting system startup without warning. Only two units are affected in the U.S.
Philips Medical Systems Nederland B.V. recalled 5,067 Allura Xper FD20 devices on September 3, 2025. The BIOS battery may deplete unexpectedly, halting the system's start-up process. This issue affects models 722006, 722012, and 722028 and poses a high risk to patient safety.
Major Pharmaceuticals recalled Sulfamethoxazole and Trimethoprim tablets on September 2, 2025, due to contamination concerns. A foreign substance was found in the packaging material, although the tablets themselves remain unaffected. Consumers should stop using the product immediately and consult healthcare providers.
Cardinal Health recalled Sulfamethoxazole and Trimethoprim tablets on September 2, 2025, due to contamination risks. A specific lot contained a foreign substance with a detected micro-organism, although no contamination was found on the tablets. Consumers must stop using the product immediately and seek guidance from healthcare providers.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.